HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Avobenzone-containing "broad spectrum" sunscreens require UVA testing -- FDA proposal.

This article was originally published in The Rose Sheet

Executive Summary

AVOBENZONE-CONTAINING "BROAD SPECTRUM" SUNSCREENS NEED UVA/UVB TESTING prior to marketing, FDA stated in a Sept. 16 proposed rule amending the sunscreen tentative final monograph. The proposal would allow the marketing of "broad spectrum" sunscreen products containing avobenzone alone and in combination with some Category I sunscreen ingredients as long as the products are first tested for their protection against both UVA and UVB rays.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS003236

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel